Lord, Abbett & Co
INSP icon

Lord, Abbett & Co’s Inspire Medical Systems INSP Stock Holding History

Lord, Abbett & Co’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-102,164
Closed -$20.3M – 552
2023
Q3 		$20.3M Sell
102,164
-348,375
-77% -$87.9M 0.08% 322
2023
Q2 		$146M Buy
450,539
+3,771
+0.8% +$1.08M 0.5% 38
2023
Q1 		$105M Buy
446,768
+7,196
+2% +$1.82M 0.38% 71
2022
Q4 		$111M Sell
439,572
-71,875
-14% -$15.3M 0.4% 67
2022
Q3 		$90.7M Buy
511,447
+162,076
+46% +$32.6M 0.33% 82
2022
Q2 		$63.8M Sell
349,371
-72,970
-17% -$14.6M 0.23% 122
2022
Q1 		$108M Buy
422,341
+14,452
+4% +$3.3M 0.29% 92
2021
Q4 		$93.8M Buy
407,889
+9,518
+2% +$2.32M 0.21% 153
2021
Q3 		$92.8M Buy
398,371
+150,886
+61% +$31.5M 0.22% 147
2021
Q2 		$47.8M Sell
247,485
-749,098
-75% -$149M 0.12% 271
2021
Q1 		$206M Buy
996,583
+393,016
+65% +$83.5M 0.53% 33
2020
Q4 		$114M Sell
603,567
-66,612
-10% -$10.9M 0.3% 99
2020
Q3 		$86.5M Buy
670,179
+26,303
+4% +$2.9M 0.28% 110
2020
Q2 		$56M Sell
643,876
-39,954
-6% -$3.07M 0.2% 162
2020
Q1 		$41.2M Sell
683,830
-298,638
-30% -$22.1M 0.18% 178
2019
Q4 		$72.9M Sell
982,468
-108,819
-10% -$6.99M 0.24% 120
2019
Q3 		$66.6M Buy
1,091,287
+96,140
+10% +$6.33M 0.23% 129
2019
Q2 		$60.4M Buy
995,147
+46,047
+5% +$2.48M 0.2% 174
2019
Q1 		$53.9M Buy
949,100
+168,743
+22% +$9.12M 0.18% 186
2018
Q4 		$33M Buy
780,357
+541,844
+227% +$23M 0.12% 262
2018
Q3 		$10M Buy
+238,513
New +$11.2M 0.03% 622

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Lord, Abbett & Co's INSP Position: Q4 2023 in Review

Lord, Abbett & Co sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 102,164 shares — an estimated $20.3M sold.

Lord, Abbett & Co first reported a position in INSP in Q3 2018 and held it in 21 quarters. The position peaked at $206M in Q1 2021. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • Lord, Abbett & Co reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 102,164 Inspire Medical Systems shares in Q4 2023, an estimated $20.3M.
  • Lord, Abbett & Co first reported a position in Inspire Medical Systems in Q3 2018 and held it in 21 quarters.
  • Lord, Abbett & Co's Inspire Medical Systems position peaked at $206M in Q1 2021.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Lord, Abbett & Co's 13F filing for Q4 2023, filed 12 Feb 2024.